All PlansCoverageMedium impact
Recall: Quinapril-Hctz
UPMC Health Plan·Cardiology, Internal Medicine, Family Medicine +1 more·Pharmacy
We identified it
Aug 7, 2026
Summary
Aurobindo Pharma USA Inc. has recalled two lots of quinapril-hydrochlorothiazide tablets due to detection of N-nitrosoquinapril impurity exceeding acceptable daily intake levels. This is a pharmaceutical safety recall affecting patients currently prescribed this medication combination; billing teams must be aware for potential claim adjustments related to medication replacements or therapy changes.
Action Required
Immediately: Notify providers and clinical staff of this medication recall. Billing team should monitor for claim denials or adjustments related to affected patient prescriptions and be prepared to process claims for alternative antihypertensive medications as providers switch patients off recalled lots. Coordinate with pharmacy department to identify affected patients in practice records. Document all recall-related medication changes in patient accounts for future reference and potential liability tracking.